Ursodeoxycholic acid ameliorates apoptotic cascade in the rotenone model of Parkinson's disease: Modulation of mitochondrial perturbations
The DOI matches its Crossref record; 70 of the 71 references it cites were found in a registry or an index.
Abstract
The recent emergence of ursodeoxycholic acid (UDCA) as a contender in modifying neurotoxicity in human dopaminergic cells as well as its recognized anti-apoptotic and anti-inflammatory potentials in various hepatic pathologies raised impetus in investigating its anti-parkinsonian effect in rat rotenone model. UDCA prominently improved motor performance in the open field test and halted the decline in the striatal dopamine content. Meanwhile, it improved mitochondrial function as verified by elevation of ATP associated with preservation of mitochondrial integrity as portrayed in the electron microscope examination. In addition, through its anti-inflammatory potential, UDCA reduced the rotenone-induced nuclear factor-κB expression and tumor necrosis factor alpha level. Furthermore, UDCA amended alterations in Bax and Bcl-2 and reduced the activities of caspase-8, caspase-9, and caspase-3, indicating that it suppressed rotenone-induced apoptosis via modulating both intrinsic and extrinsic pathways. In conclusion, UDCA can be introduced as a novel approach for the management of Parkinson's disease via anti-apoptotic and anti-inflammatory mechanisms. These effects are probably linked to dopamine synthesis and mitochondrial regulation.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Multiple in vivo studies have demonstrated the neuroprotective effects of UDCA and TUDCA in counteracting mitochondrial dysfunction, oxidative stress, and neuroinflammation within PD mouse models.386–392”
From Microbiota–gut–brain axis and its therapeutic applications in neurodegenerative diseases (2024) · cites this paper as [391]
Citations
Cites
Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method
Livak, K. J., & Schmittgen, T. D. (2001) · Methods · doi:10.1006/meth.2001.1262 · Cited by 180,860
Mutation of the mouse klotho gene leads to a syndrome resembling ageing
Kuro-o, M., Matsumura, Y., Aizawa, H., Kawaguchi, H., Suga, T., Utsugi, T., Ohyama, Y., Kurabayashi, M., Kaname, T., Kume, E., et al. (1997) · Nature · doi:10.1038/36285 · Cited by 3,837
Luo, X., Budihardjo, I., Zou, H., Slaughter, C., & Wang, X. (1998) · Cell · doi:10.1016/s0092-8674(00)81589-5 · Cited by 3,626
(2012) · Hepatogastroenterology · doi:10.5754/hge12469 · Cited by 3,178
Mammalian Caspases: Structure, Activation, Substrates, and Functions During Apoptosis
Earnshaw, W. C., Martins, L. M., & Kaufmann, S. H. (1999) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.68.1.383 · Cited by 2,760
Mitochondrial Complex I Deficiency in Parkinson's Disease
Schapira, A. H. V., Cooper, J. M., Dexter, D., Clark, J. B., Jenner, P., & Marsden, C. D. (1990) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1990.tb02325.x · Cited by 2,283 · cited 1×
“Mitochondrial dysfunction caused by selective inhibition of complex I (CI) is also a crucial culprit behind degeneration of dopaminergic neurons [10, 11].”
Lees, A. J., Hardy, J., & Revesz, T. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60492-x · Cited by 1,956
MITOCHONDRIAL COMPLEX I DEFICIENCY IN PARKINSON'S DISEASE
Schapira, A. H. V., Cooper, J. M., Dexter, D., Jenner, P., Clark, J. B., & Marsden, C. D. (1989) · The Lancet · doi:10.1016/s0140-6736(89)92366-0 · Cited by 1,756
Li, N., Ragheb, K., Lawler, G., Sturgis, J., Rajwa, B., Melendez, J. A., & Robinson, J. P. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m210432200 · Cited by 1,433
Blum, D., Torch, S., Lambeng, N., Nissou, M.-F., Benabid, A.-L., Sadoul, R., & Verna, J.-M. (2001) · Progress in Neurobiology · doi:10.1016/s0301-0082(01)00003-x · Cited by 1,246
Control of mitochondrial apoptosis by the Bcl-2 family
Brunelle, J. K., & Letai, A. (2009) · Journal of Cell Science · doi:10.1242/jcs.031682 · Cited by 929
Paumgartner, G., & Beuers, U. (2002) · Hepatology · doi:10.1053/jhep.2002.36088 · Cited by 748
Keeney, P. M., Xie, J., Capaldi, R. A., & Bennett, J. P. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.0984-06.2006 · Cited by 747
Pathoanatomy of Parkinson’s disease
Braak, H., & Braak, E. (2000) · Journal of Neurology · doi:10.1007/pl00007758 · Cited by 693 · cited 1×
“Dopaminergic neuron death and cholinergic dysfunction due to degenerative events in the substantia nigra and midbrain nuclei mainly account for the characteristic motor symptoms clinically manifested in this disease [12].”
del Zoppo, G., Ginis, I., Hallenbeck, J. M., Iadecola, C., Wang, X., & Feuerstein, G. Z. (2000) · Brain Pathology · doi:10.1111/j.1750-3639.2000.tb00247.x · Cited by 662
Antonsson, B. E., Montessuit, S., Lauper, S., Eskes, R., & Martinou, J. (2000) · Biochemical Journal · doi:10.1042/0264-6021:3450271 · Cited by 645
CFTR regulates outwardly rectifying chloride channels through an autocrine mechanism involving ATP
Schwiebert, E. M., Egan, M. E., Hwang, T.-H., Fulmer, S. B., Allen, S. S., Cutting, G. R., & Guggino, W. B. (1995) · Cell · doi:10.1016/s0092-8674(05)80011-x · Cited by 643
Cassatella, M. A., Meda, L., Bonora, S., Ceska, M., & Constantin, G. (1993) · The Journal of experimental medicine · doi:10.1084/jem.178.6.2207 · Cited by 507
Rotenone destroys dopaminergic neurons and induces parkinsonian symptoms in rats
Alam, M., & Schmidt, W. J. (2002) · Behavioural Brain Research · doi:10.1016/s0166-4328(02)00180-8 · Cited by 473
Apoptosis in Parkinson's disease: Signals for neuronal degradation
Tatton, W. G., Chalmers-Redman, R., Brown, D., & Tatton, N. (2003) · Annals of Neurology · doi:10.1002/ana.10489 · Cited by 397
Bile acids: regulation of apoptosis by ursodeoxycholic acid
Amaral, J. D., Viana, R. J. S., Ramalho, R. M., Steer, C. J., & Rodrigues, C. M. P. (2009) · Journal of Lipid Research · doi:10.1194/jlr.r900011-jlr200 · Cited by 363
Rodrigues, C. M. P., Fan, G., Wong, P. Y., Kren, B. T., & Steer, C. J. (1998) · Molecular Medicine · doi:10.1007/bf03401914 · Cited by 334
Basic Techniques for Transmission Electron Microscopy
(1986) · Elsevier eBooks · doi:10.1016/b978-0-12-333926-3.x5001-5 · Cited by 327
Caspases: Keys in the Ignition of Cell Death
Denault, J.-B., & Salvesen, G. S. (2002) · Chemical Reviews · doi:10.1021/cr010183n · Cited by 309
Keene, C. D., Rodrigues, C. M. P., Eich, T., Chhabra, M. S., Steer, C. J., & Low, W. C. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.162362299 · Cited by 306
Neuroinflammation and oxidative stress: Co-conspirators in the pathology of Parkinson’s disease
Taylor, J. M., Main, B. S., & Crack, P. J. (2013) · Neurochemistry International · doi:10.1016/j.neuint.2012.12.016 · Cited by 303
Rotenone Model of Parkinson Disease
Panov, A., Dikalov, S., Shalbuyeva, N., Taylor, G., Sherer, T., & Greenamyre, J. T. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m508628200 · Cited by 288
Neurodegeneration and Inflammation in Parkinson's disease
Phani, S., Loike, J. D., & Przedborski, S. (2012) · Parkinsonism & Related Disorders · doi:10.1016/s1353-8020(11)70064-5 · Cited by 263 · cited 1×
“Growing evidence verifies that neurodegeneration in PD likely involves inflammation [2, 3] and apoptosis in sensitive neurons [4, 5] associatedwith deranged redox status [6, 7].”
Rogers, J., Mastroeni, D., Leonard, B., Joyce, J., & Grover, A. (2007) · International Review of Neurobiology · doi:10.1016/s0074-7742(07)82012-5 · Cited by 260
Rodrigues, C. M., Ma, X., Linehan-Stieers, C., Fan, G., Kren, B. T., & Steer, C. J. (1999) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4400560 · Cited by 260
Jiang, X., Jiang, H., Shen, Z., & Wang, X. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1417253111 · Cited by 220 · cited 1×
“Such oligomers can induce mitochondrial membrane permeability [34] resulting in the leakage of cytochrome c and other apoptogenic proteins which initiate apoptotic caspase activation [35].”
Rodrigues, C. M. P., Solá, S., Nan, Z., Castro, R. E., Ribeiro, P. S., Low, W. C., & Steer, C. J. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1031632100 · Cited by 210
Ursodeoxycholic acid in cholestasis: linking action mechanisms to therapeutic applications
Roma, M. G., Toledo, F. D., Boaglio, A. C., Basiglio, C. L., Crocenzi, F. A., & Sánchez Pozzi, E. J. (2011) · Clinical Science · doi:10.1042/cs20110184 · Cited by 208
Oxidative and nitrative protein modifications in Parkinson's disease
Danielson, S. R., & Andersen, J. K. (2008) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2008.03.005 · Cited by 202
The Unexpected Uses of Urso- and Tauroursodeoxycholic Acid in the Treatment of Non-liver Diseases
Vang, S., Longley, K., Steer, C. J., & Low, W. C. (2014) · Global Advances in Health and Medicine · doi:10.7453/gahmj.2014.017 · Cited by 201
Isenberg, J. S. (2000) · Toxicological Sciences · doi:10.1093/toxsci/53.2.340 · Cited by 187
Neuroprotection by a Bile Acid in an Acute Stroke Model in the Rat
Rodrigues, C. M. P., Spellman, S. R., Solá, S., Grande, A. W., Linehan-Stieers, C., Low, W. C., & Steer, C. J. (2002) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/00004647-200204000-00010 · Cited by 160
Newhouse, K. (2004) · Toxicological Sciences · doi:10.1093/toxsci/kfh089 · Cited by 157
Keene, C. D., Rodrigues, C. M. P., Eich, T., Linehan-Stieers, C., Abt, A., Kren, B. T., Steer, C. J., & Low, W. C. (2001) · Experimental Neurology · doi:10.1006/exnr.2001.7755 · Cited by 144
NEUMAN, M., ANGULO, P., MALKIEWICZ, I., JORGENSEN, R., SHEAR, N., DICKSON, E. R., HABER, J., KATZ, G., & LINDOR, K. (2002) · Journal of Gastroenterology and Hepatology · doi:10.1046/j.1440-1746.2002.02672.x · Cited by 142
Miura, T., Ouchida, R., Yoshikawa, N., Okamoto, K., Makino, Y., Nakamura, T., Morimoto, C., Makino, I., & Tanaka, H. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m107098200 · Cited by 137
Rodrigues, C. M. P., Solá, S., Silva, R., & Brites, D. (2000) · Molecular Medicine · doi:10.1007/bf03401828 · Cited by 131
Parry, G. J., Rodrigues, C. M. P., Aranha, M. M., Hilbert, S. J., Davey, C., Kelkar, P., Low, W. C., & Steer, C. J. (2010) · Clinical Neuropharmacology · doi:10.1097/wnf.0b013e3181c47569 · Cited by 128
Green, D. R., & Beere, H. M. (2000) · Nature · doi:10.1038/35011175 · Cited by 128
Solá, S., Castro, R. E., Laires, P. A., Steer, C. J., & Rodrigues, C. M. P. (2003) · Molecular Medicine · doi:10.2119/2003-00042.rodrigues · Cited by 118
Antioxidant properties of ursodeoxycholic acid
Lapenna, D., Ciofani, G., Festi, D., Neri, M., Pierdomenico, S. D., Giamberardino, M. A., & Cuccurullo, F. (2002) · Biochemical Pharmacology · doi:10.1016/s0006-2952(02)01391-6 · Cited by 116
Bile acids and apoptosis modulation: an emerging role in experimental Alzheimer's disease
Ramalho, R. M., Viana, R. J. S., Low, W. C., Steer, C. J., & Rodrigues, C. M. P. (2008) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2007.12.001 · Cited by 114
Fiorotto, R., Spirlì, C., Fabris, L., Cadamuro, M., Okolicsànyi, L., & Strazzabosco, M. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.08.071 · Cited by 111
Duan, W.-M., Rodrigures, C. M. P., Zhao, L.-R., Steer, C. J., & Low, W. C. (2002) · Cell Transplantation · doi:10.3727/096020198389960 · Cited by 108
Apoptosis: molecular mechanisms and pathogenicity
Rastogi, R. P., R., & Sinha, R. P. (2010) · Technische Universität Dortmund · doi:10.17877/de290r-8930 · Cited by 106 · cited 1×
“TNF-α is a potent proinflammatory cytokine which can eventually induce apoptosis through activation of TNF receptor-1, one of the so-called “death receptors” with the consequent activation of caspase-8, the initiator caspase of the extrinsic apoptotic pathway [49].”
Dose-dependent antiinflammatory effect of ursodeoxycholic acid in experimental colitis
Martínez-Moya, P., Romero‐Calvo, I., Requena, P., Hernández‐Chirlaque, C., Aranda, C. J., González, R., Zarzuelo, A., Suárez, M. D., Martínez‐Augustin, O., Marín, J. J. G., et al. (2012) · International Immunopharmacology · doi:10.1016/j.intimp.2012.11.017 · Cited by 103
van den Buuse, M., & de Jong, W. (1989) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)24140-4 · Cited by 98
Stimulation of ATP secretion in the liver by therapeutic bile acids
Nathanson, M. H., Burgstahler, A. D., Masyuk, A. I., & LaRusso, N. F. (2001) · Biochemical Journal · doi:10.1042/0264-6021:3580001 · Cited by 88
Ursodeoxycholic acid diminishes Fas-ligand-induced apoptosis in mouse hepatocytes
Azzaroli, F., Mehal, W., Soroka, C. J., Wang, L., Lee, J., Crispe, N., & Boyer, J. L. (2002) · Hepatology · doi:10.1053/jhep.2002.34511 · Cited by 84
Shah, S. A., Volkov, Y., Arfin, Q., Abdel‐Latif, M. M., & Kelleher, D. (2006) · International Journal of Cancer · doi:10.1002/ijc.21365 · Cited by 84
Localization of the Ecto-ATPase (Ecto-nucleotidase) in the Rat Hepatocyte Plasma Membrane
Lin, S. (1989) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)71693-1 · Cited by 81
Castro, R. E., Solá, S., Ramalho, R. M., Steer, C. J., & Rodrigues, C. M. P. (2004) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.104.070532 · Cited by 66
Chun, H. S., & Low, W. C. (2011) · Toxicology · doi:10.1016/j.tox.2011.11.020 · Cited by 62
Rotenone-induced apoptosis and role of calcium: a study on Neuro-2a cells
Swarnkar, S., Goswami, P., Kamat, P. K., Gupta, S., Patro, I. K., Singh, S., & Nath, C. (2012) · Archives of Toxicology · doi:10.1007/s00204-012-0853-z · Cited by 60
Joo, S. S., Won, T., & Lee, D. I. (2004) · Archives of Pharmacal Research · doi:10.1007/bf02975850 · Cited by 54
Basic techniques for transmission electron microscopy
Hanker, J. S., & Giammara, B. L. (1987) · Micron and Microscopica Acta · doi:10.1016/0739-6260(87)90019-0 · Cited by 54
Liver protective effect of ursodeoxycholic acid includes regulation of ADAM17 activity
Lhotská, H., Chalupský, K., Zbodakova, O., Kanchev, I., Jiroušková, M., Gregor, M., & Sedláček, R. (2013) · BMC Gastroenterology · doi:10.1186/1471-230x-13-155 · Cited by 49
Ishizaki, K., Iwaki, T., Kinoshita, S., Koyama, M., Fukunari, A., Tanaka, H., Tsurufuji, M., Sakata, K., Maeda, Y., Imada, T., et al. (2007) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2007.08.031 · Cited by 39
Waking action of ursodeoxycholic acid (UDCA) involves histamine and GABAA receptor block
Yanovsky, Y., Schubring, S. R., Yao, Q., Zhao, Y., Li, S., May, A., Haas, H. L., Lin, J.-S., & Sergeeva, O. A. (2012) · PLoS ONE · doi:10.1371/journal.pone.0042512 · Cited by 34 · cited 1×
“Besides, clinical [14] and experimental [15] studies verified that the drug crosses the blood-brain barrier.”
Liu, J. H., Zhou, C., Zhang, Z., Wang, L., Jing, Z., & Wang, Z. (2012) · CNS Neuroscience & Therapeutics · doi:10.1111/j.1755-5949.2012.00348.x · Cited by 28
Rodríguez‐Ortigosa, C. M., Banales, J. M., Olivas, I., Uriarte, I., Marín, J. J. G., Corrales, F. J., Medina, J. F., & Prieto, J. (2010) · Hepatology · doi:10.1002/hep.23709 · Cited by 26
Tran, T. D., Ryu, H.-C., Yoo, S.-H., & Rhee, D. (2008) · Biochemical Pharmacology · doi:10.1016/j.bcp.2008.03.008 · Cited by 23
Neuroprotection by Pergolide Against Levodopa-Induced Cytotoxicity of Neural Stem Cells
Liu, W., Chen, Y., Li, B., Lü, G., & Chen, S. (2004) · Neurochemical Research · doi:10.1007/s11064-004-7027-1 · Cited by 15
Ursodeoxycholic acid (UDCA) suppresses liver interleukin 2 mRNA in the cholangitis model.
Miyaguchi, S., & Mori, M. (2005) · PubMed · Cited by 13
Rotenone-induced Parkinson`s Like Disease: Modulating Role of Coenzyme Q10
., H. M. A.-E. G., Abdallah, D. M., & El-Abhar, H. S. (2004) · Journal of Biological Sciences · doi:10.3923/jbs.2004.568.574 · Cited by 13
Cited by
Microbiota–gut–brain axis and its therapeutic applications in neurodegenerative diseases
Loh, J. S., Mak, W. Q., Tan, L. K. S., Ng, C. X., Chan, H. H., Yeow, S. H., Foo, J. B., Ong, Y. S., How, C. W., & Khaw, K. Y. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01743-1 · Cited by 1,193
Mitochondrial dysfunction in Parkinson’s disease – a key disease hallmark with therapeutic potential
Henrich, M. T., Oertel, W. H., Surmeier, D. J., & Geibl, F. F. (2023) · Molecular Neurodegeneration · doi:10.1186/s13024-023-00676-7 · Cited by 406
New insights into the complex role of mitochondria in Parkinson’s disease
Grünewald, A., Kumar, K. R., & Sue, C. M. (2019) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2018.09.003 · Cited by 364
The role of gut dysbiosis in Parkinson’s disease: mechanistic insights and therapeutic options
Wang, Q., Luo, Y., Ray Chaudhuri, K., Reynolds, R., Tan, E.-K., & Pettersson, S. (2021) · Brain · doi:10.1093/brain/awab156 · Cited by 281
Mitochondrial Calcium: Effects of Its Imbalance in Disease
Matuz-Mares, D., González-Andrade, M., Araiza-Villanueva, M. G., Vilchis-Landeros, M. M., & Vázquez-Meza, H. (2022) · Antioxidants · doi:10.3390/antiox11050801 · Cited by 266
Metadata
- Authors
- Abdelkader, N. F., Safar, M. M., & Salem, H. A.
- Affiliations
- Cairo University (EG)
- Corresponding author
- Safar, Marwa M.
- Venue
- Molecular Neurobiology
- Published
- 2014-12-15
- Volume
- 53
- Issue
- 2
- Pages
- 810-817
- ISSN
- 0893-7648 (ISSN-L)
- 1559-1182
- OpenAlex
- W2091788949
- Semantic Scholar
- fcc70b503c55e0a071b3917e54d4274523b7290e
- Cited by
- 127
- References
- 71
- Citations by year
- 2026: 9 · 2025: 15 · 2024: 12 · 2023: 15 · 2022: 14 · 2021: 17 · 2020: 17 · 2019: 9 · 2018: 10 · 2017: 4 · 2016: 3 · 2015: 1
- FWCI
- 1.74
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Molecular Neurobiology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Ain Shams University
- National Institutes of Health
- Topics
- Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nuclear Receptors and Signaling
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Coenzyme Q10 studies and effects
- Keywords
- ursodeoxycholic acid, Parkinson's disease, rotenone, apoptosis, mitochondrial dysfunction, dopaminergic neurons, neuroprotection, anti-inflammatory activity, NF-κB, TNF-α, Bax, Bcl-2, caspase-3, caspase-8, caspase-9, striatal dopamine, ATP production, motor performance
- MeSH terms
- Adenosine Triphosphate, Animals, Behavior, Animal, Disease Models, Animal, Dopamine, Gene Expression Regulation, Male, Mitochondria, Neurons, Parkinson Disease, RNA, Messenger, Rotenone, Ursodeoxycholic Acid, Neostriatum, Rats, Wistar, Apoptosis, Caspases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.